US Patent 11365244 Anti-PHF-tau antibodies and uses thereof
Patent 11365244 was granted and assigned to Janssen Biotech on June, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Kristof Van Kolen0
Marc Mercken0
Marianne Borgers0
Thomas Malia0
Edits on 4 Apr, 2023
Golden AI
Infobox
Patent Citations
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
113652440
Date of Patent
June 21, 2022
0Patent Application Number
169866150
Date Filed
August 6, 2020
0Patent Citations
Patent Primary Examiner
Golden AI
Infobox
Patent Citations
Edits on 22 Jun, 2022
Golden AI
Edits made to:
Infobox (+10 properties)
Article (+305 characters)
US Patent 11365244 Anti-PHF-tau antibodies and uses thereof
Article
Monoclonal anti-PHF-tau antibodies and antigen-binding fragments thereof are described. Also described are nucleic acids encoding the antibodies, compositions comprising the antibodies, methods of producing the antibodies and using the antibodies for treating or preventing conditions such as tauopathies.
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11365244
Date of patent
June 21, 2022
Patent application number
16986615
Date Filed
August 6, 2020
Patent citations
Patent primary examiner
Find more entities like US Patent 11365244 Anti-PHF-tau antibodies and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
